Case Control Study
Copyright ©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 403-417
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.403
Table 6 Determinants of bone mineral density using multivariate forward linear regression analysis
Factors
B
SE
t value
P value
95%CI
Lower
Upper
Lumbar spine BMD
Age-0.0020.001-3.754< 0.001-0.003-0.001
Height0.0030.0013.669< 0.0010.0010.005
Diabetes duration-0.0030.001-2.6650.008-0.005-0.001
Albumin-0.0040.001-2.8640.004-0.007-0.001
Cr0.0010.0001.9830.0480.0000.001
β-CTX-0.0890.033-2.7240.007-0.153-0.025
TP1NP-0.0010.000-1.6330.103-0.0020.000
ASMI-0.0400.016-2.4490.015-0.072-0.008
Lean mass index0.0360.0084.498< 0.0010.0200.051
Femoral neck BMD
Age-0.0030-6.8< 0.001-0.003-0.002
Height0.0030.0014.672< 0.0010.0020.004
Diabetes duration-0.0020.001-3.617< 0.001-0.004-0.001
Albumin-0.0030.001-2.6980.007-0.005-0.001
β-CTX-0.1000.018-5.589< 0.001-0.135-0.065
Android/gynoid ratio-0.0450.02-2.2590.024-0.084-0.006
ASMI0.0110.0120.9630.336-0.0120.034
Lean mass index0.0140.0062.4570.0140.0030.025
Total hip BMD
Age-0.0020.000-5.451< 0.001-0.003-0.001
Weight0.0020.0013.1420.0020.0010.003
Diabetes duration-0.0020.001-3.3270.001-0.004-0.001
β-CTX-0.0820.019-4.403< 0.001-0.118-0.045
Android/gynoid ratio-0.0410.02-2.0030.046-0.081-0.001
Lean mass index0.0200.0036.266< 0.0010.0140.026